COMMUNIQUÉS West-GlobeNewswire

La Fondation ACT salue la décision du ministre de l'Éducation du Québec d’étendre les défibrillateurs à toutes les écoles publiques

06/06/2024 - 17:27

OTTAWA, 06 juin 2024 (GLOBE NEWSWIRE) -- La Fondation (ACT) des soins avancés en urgence coronarienne accueille favorablement l’annonce faite par le ministre de l'Éducation, Bernard Drainville, visant à assurer la [...]

Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

06/06/2024 - 17:15

In t he HBV003 trial, 67% of participants had HBsAg <10 IU/mL and 19% of participants had undetectable HBsAg when assessed for NUC discontinuation (end of treatment) or later, and 76% of participants were eligible [...]

Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels

06/06/2024 - 17:15

Data highlighted in oral presentation at the European Association for the Study of the Liver (EASL) Congress WARMISTER, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or [...]

Legend Senior Living Assumes Management, Renames Four Florida Properties, Increases Portfolio to 59

06/06/2024 - 17:06

WICHITA, Kan., June 06, 2024 (GLOBE NEWSWIRE) -- Legend Senior Living announced today that it has assumed management of four senior living residences in Florida, which increases the number of properties in the company's [...]

Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split

06/06/2024 - 17:00

CHATHAM, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), fully-integrated biopharmaceutical company with marketed products and a pipeline of development [...]

BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit

06/06/2024 - 16:00

iC³® is hosted by BioNTX in collaboration with Arlington Economic Development Corporation DALLAS, June 06, 2024 (GLOBE NEWSWIRE) -- BioNTX , the leading biotechnology and healthcare innovation trade organization in [...]

AssistRx Expands Tech + Talent Footprint with New Facilities in Florida and Kansas

06/06/2024 - 16:00

Additional space accommodates near-doubling of workforce to support innovative therapy initiation and patient support service offerings ORLANDO, Fla., June 06, 2024 (GLOBE NEWSWIRE) -- AssistRx , the advanced therapy [...]

U.S. Oral Surgery Management Secures New Partner Practices in Colorado, Kansas and California

06/06/2024 - 15:45

IRVING, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) continues its growth momentum, adding three new partner practices to its network of premier oral and maxillofacial surgeons. [...]

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

06/06/2024 - 15:31

HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of [...]

Streamline Today, Predict Tomorrow: MNDR's AI-Powered Health Operating System Optimizes Operations and Powers Predictive Healthcare

06/06/2024 - 15:28

SINGAPORE, June 06, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”) , a leading Asia-Pacific telehealth provider, today announces the latest major update to its cloud- [...]

Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study

06/06/2024 - 15:14

Total Patient Enrollment of 90 Towards Overall Target of 240 DALLAS, June 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused [...]

Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day

06/06/2024 - 15:02

Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard of care for opioid overdose reversal in a community setting New topline survey findings reinforce the need for continued [...]

Aeroflow Health Announces Lactation Care Services are Now Available to Blue Cross Blue Shield Patients Across the Country

06/06/2024 - 15:00

Aeroflow continues to expand access to postpartum care for new mothers with in-network lactation resources for BCBS patients at little to no additional cost ASHEVILLE, N.C., June 06, 2024 (GLOBE NEWSWIRE) -- Aeroflow [...]

Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab

06/06/2024 - 15:00

Qualitative improvements in PET imaging seen in 80% of non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access patients receiving intranasal foralumab for at least 6-months. FDA Allowance for an [...]

Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET

06/06/2024 - 15:00

CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the time of [...]

Safety Shot Partners with Capital Drugs To Launch World’s First Beverage To Reduce Blood Alcohol Content in 300 Pharmacies Across the Country

06/06/2024 - 14:35

The First of its Kind Vitamin-Packed, Wellness Beverage Brand Continues to Amplify its In-Store Availability Nationwide JUPITER, FL, June 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company), [...]

Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer

06/06/2024 - 14:30

PARIS, FRANCE, 06 June 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Josep Catllà as EVP, Chief Corporate Affairs Officer, effective [...]

Ipsen nomme Josep Catllà, en qualité de Vice-Président Exécutif, Chief Corporate Affairs Officer

06/06/2024 - 14:30

PARIS, FRANCE, 06 juin 2024 - Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique mondial de spécialité, annonce aujourd’hui la nomination de Josep Catllà en tant que Vice-Président Exécutif, Chief Corporate [...]

Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System

06/06/2024 - 14:30

LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune System by Disrupting the Process of RNA Splicing PASADENA, CA, June 06, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE [...]